NASDAQ:IMMU
Delisted
Immunomedics Stock News
$87.86
+0 (+0%)
At Close: May 27, 2022
Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports
12:00am, Saturday, 12'th Sep 2020
Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports
Immunomedics, Inc. (NASDAQ:IMMU) Shares Acquired by State Board of Administration of Florida Retirement System
06:20am, Wednesday, 26'th Aug 2020
State Board of Administration of Florida Retirement System boosted its stake in Immunomedics, Inc. (NASDAQ:IMMU) by 201.7% in the second quarter, according to the company in its most recent disclosure
Rafferty Asset Management LLC Has $1.09 Million Position in Immunomedics, Inc. (NASDAQ:IMMU)
07:04am, Tuesday, 25'th Aug 2020
Rafferty Asset Management LLC increased its position in shares of Immunomedics, Inc. (NASDAQ:IMMU) by 54.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securiti
MAITLAND, Fla.--(BUSINESS WIRE)--Advanced Dermatology and Cosmetic Surgery (ADCS), a national leader in dermatology care, today announced that Justin Simoncini has been promoted to Chief Strategy Offi
Immunomedics Announces FDA Approval of Samsung Biologics as Antibody Manufacturer for Trodelvy™
12:00pm, Monday, 17'th Aug 2020
Approval enhances long-term supply of TrodelvyMORRIS PLAINS, N.J., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceu
Affimed N.V. (AFMD) CEO Adi Hoess on Q2 2020 Results - Earnings Call Transcript
03:41pm, Tuesday, 11'th Aug 2020
Affimed N.V. (NASDAQ:AFMD) Q2 2020 Earnings Conference Call August 11, 2020 8:30 a.m.
Vident Investment Advisory LLC Acquires New Stake in Immunomedics, Inc. (NASDAQ:IMMU)
12:06am, Monday, 10'th Aug 2020
Vident Investment Advisory LLC bought a new position in shares of Immunomedics, Inc. (NASDAQ:IMMU) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 14,619
DS Announces Clinical Trial Collaboration with AZ to Evaluate Patritumab Deruxtecan (U3-1402) in Combination with TAGRISSO in EGFR-Mutated NSCLC
Immunomedics (IMMU) Reports Q2 Loss, Lags Revenue Estimates
10:35pm, Wednesday, 05'th Aug 2020
Immunomedics (IMMU) delivered earnings and revenue surprises of 11.76% and -19.08%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Immunomedics Reports Second Quarter 2020 Results and Provides Corporate Update
08:00pm, Wednesday, 05'th Aug 2020
Encouraging early adoption of Trodelvy™ in U.S. with $20.1M net sales in first two months of launch Confirmatory Phase 3 ASCENT study met primary endpoint of progression-free survival and key secon
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
12:00am, Wednesday, 05'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
ABIOMED, Inc. (NASDAQ: ABMD)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Annexon Inc (NASDAQ: ANNX)
Atossa...
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
2 "Strong Buy" Healthcare Stocks That Could Be the Next M&A Target
11:54pm, Wednesday, 29'th Jul 2020
Which stocks have been the stars of 2020? Biotechs. Amid the onset of the global health crisis, companies advancing COVID-19 vaccines, treatments and
2 “Strong Buy” Healthcare Stocks That Could Be the Next M&A Target
07:31pm, Wednesday, 29'th Jul 2020
Which stocks have been the stars of 2020? Biotechs. Amid the onset of the global health crisis, companies advancing COVID-19 vaccines, treatments and testing kits have seen their shares take off rapid